Inovio Biomedical Corporation (AMEX: INO) and VGX Pharmaceuticals, Inc., a privately held DNA vaccine developer, announced the signing of a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE